Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore biomarker testing strategies for antibody-drug conjugates (ADCs) in cancer treatment through this 50-minute webinar presented by Prof. Giancarlo Pruneri, Full Professor in Pathology at the University of Milan and Chair of the Department of Advanced Diagnostics at the National Cancer Institute of Milan. Learn how ADCs function as targeted therapies that combine monoclonal antibodies directed against specific antigens with highly potent cytotoxic agents to deliver treatment directly to tumor cells while sparing normal tissue. Discover the rapidly advancing field of ADC development and their promising results in cancer treatment. Gain insights into the critical role of biomarker testing in identifying appropriate patients for ADC therapy and optimizing treatment outcomes. Understand the molecular mechanisms underlying ADC efficacy and the diagnostic approaches used to select patients who will benefit most from these innovative targeted therapies.
